How to use functional imaging information for radiotherapy planning

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 461-463

  Grosu, Anca Ligia ^a   Nestle, Ursula ^a   Weber, Wolfgang A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3' FLUOROTHYMIDINE F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; TRACER;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FUNCTIONAL ASSESSMENT; GLIOMA; HEAD AND NECK TUMOR; HUMAN; HYPOXIA; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT PLANNING; TUMOR VASCULARIZATION; TUMOR VOLUME;

BRAIN NEOPLASMS; CELL PROLIFERATION; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 70349084520     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70090-5     Document Type: Article

References (20)

1. Nestle U., Kremp S., and Grosu A.L. Practical integration of [(18)F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
2. Nestle U., Weber W., Hentschel M., and Grosu A.L. Biological imaging in radiotherapy: role of positron emission tomography. Phys Med Biol 7 54 Suppl. 1 (2009) R1-25
3. Weber W.A., Wester H.J., Grosu A.L., et al. O-2(18F)Fluoretihyl-L-tyrosine and L-(methyl-11C)methionine uptake in brain tumors: initial results of a comparative study. Eur J Nucl Med 27 (2000) 542-549
4. Langen K.J., Jarosch M., Muhlensiepen H., et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 30 (2003) 501-508
5. Grosu A.L., Weber W.A., Feldmann H.J., et al. First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas. Int J Rad Oncol Biol Phys 47 (2000) 517-527
6. Grosu A.L., Feldmann H.J., Dick S., et al. Implications of IMT-SPECT for postoperative radiation treatment planning in patients with gliomas. Int J Rad Oncol Biol Phys 54 (2002) 842-854
7. Weber W.A., Dick S., Reidl G., et al. Correlation between postoperative 3-(123I)-Iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 42 (2001) 1144-1150
8. Grosu A.L., Weber A.W., Riedel E., et al. L-(Methyl-11C) Methionine positron emissions tomography for target delineation in resected high grade gliomas before radiation therapy. Int J Rad Oncol Biol Phys 63 (2005) 64-74
9. Grosu A.L., Weber W.A., Franz M., et al. Re-irradiation of recurrent high grade gliomas using amino-acids-PET(SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Rad Oncol Biol Phys 63 (2005) 511-519
10. Pirzkall A., Li X., Oh J., Chang S., et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Rad Oncol Biol Phys 59 1 (2004) 126-137
11. Graves E.E., Nelson S.J., Vigneron D.B., et al. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46 2 (2000) 319-326 discussion 326-8.
12. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 126-135
13. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
14. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 (2002) 91-97
15. Mizowaki T., Cohen G.N., Fung A.Y., and Zaider M. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54 5 (2002) 1558-1564
16. Grosu A.L., Souvatzoglou M., Röper B., et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 2 (2007) 541-551
17. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 4 (2001) 1171-1182
18. Lin Z., Mechalakos J., Nehmeh S., et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70 4 (2008) 1219-1228
19. Buck A.K., Hetzel M., Schirrmeister H., et al. Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging 32 5 (2005) 525-533
20. Beer A.J., Grosu A.L., Carlsen J., et al. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13 22 Pt 1 (2007) 6610-6616